Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2008-4-1
pubmed:abstractText
We previously demonstrated that chronic hyperinsulinaemia induced by drinking high levels of fructose augments adrenergic nerve-mediated vasoconstriction and suppresses vasodilatation mediated by calcitonin gene-related peptide (CGRP)-containing (CGRPergic) vasodilator nerves. In this study, the effects of pioglitazone on vascular responses induced by stimulation of adrenergic nerves, CGRPergic nerves and vasoactive agents were investigated in pithed rats given 15% fructose solution to drink (FDR).
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-10078998, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-10329404, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-10645917, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-10821338, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-10953027, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-1452295, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-14581176, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-15662559, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-15680279, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-1587398, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-15892654, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-16138267, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-1628392, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-1634611, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-16832157, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-1688944, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-17696960, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-1851784, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-2901042, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-3005557, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-3310065, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-3884667, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-7028550, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-7043185, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-7507998, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-7615805, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-7666781, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-7902428, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-8020998, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-9244372, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-9307325, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-9324108, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-9369268, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-9467183, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-9605576, http://linkedlifedata.com/resource/pubmed/commentcorrection/18246090-9831704
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
153
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1388-98
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:18246090-Administration, Oral, pubmed-meshheading:18246090-Angiotensin II, pubmed-meshheading:18246090-Animals, pubmed-meshheading:18246090-Blood Glucose, pubmed-meshheading:18246090-Blood Pressure, pubmed-meshheading:18246090-Chronic Disease, pubmed-meshheading:18246090-Disease Models, Animal, pubmed-meshheading:18246090-Hyperinsulinism, pubmed-meshheading:18246090-Hypertension, pubmed-meshheading:18246090-Hypoglycemic Agents, pubmed-meshheading:18246090-Insulin, pubmed-meshheading:18246090-Insulin Resistance, pubmed-meshheading:18246090-Male, pubmed-meshheading:18246090-Norepinephrine, pubmed-meshheading:18246090-Random Allocation, pubmed-meshheading:18246090-Rats, pubmed-meshheading:18246090-Rats, Wistar, pubmed-meshheading:18246090-Thiazolidinediones, pubmed-meshheading:18246090-Triglycerides, pubmed-meshheading:18246090-Vasoconstriction
pubmed:year
2008
pubmed:articleTitle
Pioglitazone opposes neurogenic vascular dysfunction associated with chronic hyperinsulinaemia.
pubmed:affiliation
Department of Clinical Pharmaceutical Science, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
pubmed:publicationType
Journal Article